By analyzing the metabolomics data from plasma and tumor tissues alongside subsequent expression validation, we identified L-Asparagine (L-Asn) as the differential metabolite in <i>VHL-</i>mutant RCC, with its levels significantly decreased in these tumors. Here, VHL is linked to neoplasm.